Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

Public Health, Biostatistics, Experimental Design +10

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells

H Stein, DY Mason, Johannes Gerdes et al. · Blood · 1985 · 1.8K citations · Full text

Medicine, Oncology, Pathology +17

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

DG Maloney, TM Liles, DK Czerwinski et al. · Blood · 1994 · 753 citations

Medicine, Hematology, Oncology +17

Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell Lymphoma

John G. Gribben, Arnold S. Freedman, Donna Neuberg et al. · New England Journal of Medicine · 1991 · 686 citations · Full text

Medicine, Hematology, Immunology +13

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma

G. Riethmüller, Rudolf Gruber, E. Schneider-Gädicke et al. · The Lancet · 1994 · 638 citations

Medicine, Oncology, Surgery +16